Mannkind Corp (NASDAQ:MNKD)
Industry: Healthcare

Listed 3 Consecutive Market Days. On List as of 01/23/2012 Through 01/26/2012

MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States. Its lead product candidate is AFREZZA inhalation powder, an insulin that is in late-stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia. The company is also developing MedTone and Dreamboat inhaler devices. MannKind Corporation was founded in 1991 and is headquartered in Valencia, California.

Current Quote*
Last: $5.360
Change: -0.050
Book: $198.300
Volume: 8,033,514

As Of: 12/19 14:54 PST ET
*Quotes delayed by 20min.

Graphs for MNKD


3 Month Graph


6 Month Graph


1 Year Graph